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complex that is predicted to form a pore in the cytoplasmic membrane. In M. tuberculosis this 23 complex is composed of five membrane proteins: EccB1, EccCa1, EccCb1, EccD1, EccE1. In 24 this study, we have characterized the membrane component EccE1 and found that deletion of 25 eccE1 lowers the levels of EccB1, EccCa1 and EccD1 thereby abolishing ESX-1 secretion and 26 attenuating M. tuberculosis ex vivo. Surprisingly, secretion of EspB was not affected by loss 27 of EccE1. Furthermore, EccE1 was found to be a membrane-and cell-wall associated protein 28 that needs the presence of other ESX-1 components to assemble into a stable complex at the Tuberculosis (TB), the world's leading cause of death of humans from an infectious disease, is 33 caused by the intracellular bacterium Mycobacterium tuberculosis. The development of 34 successful strategies to control TB requires better understanding of the complex interactions 35 between the pathogen and human host. We investigated the contribution of EccE1, a membrane 36 protein, to the function of the ESX-1 secretion system, the major virulence determinant of M. 37 tuberculosis. By combining genetic analysis of selected mutants with eukaryotic cell biology 38 and proteomics, we demonstrate that EccE1 is critical for ESX-1 function, secretion of effector Mycobacterium tuberculosis is a slow-growing intracellular pathogen with the ability to infect 43 and survive inside macrophages. Protein secretion is essential for mycobacterial virulence and 44 host-pathogen interactions (1). The M. tuberculosis genome encodes five specialized secretion 45 systems, referred to as ESX or Type VII systems, termed ESX-1 to . ESX systems 46 are multi-subunit apparatuses that share similar structure and secrete related proteins but have 47 different functions (3, 4) . 48 ESX-1 is involved in virulence factor secretion and pathogenesis. It is essential for phagosomal 49 rupture thereby allowing translocation to the cytosol where bacteria can induce host cell death 50 and subsequently spread to neighboring cells (6-9). Deletion or inactivation of ESX-1 does not 51 affect growth in vitro but causes attenuation of virulence in infection models (9, 10) . Indeed, 52 loss of eight genes (RD1) from the esx-1 locus is the primary attenuating deletion of the live 53 tuberculosis vaccine, Mycobacterium bovis BCG (11). The locus encoding the ESX-1 secretion 7 in ESX-1-mediated function, we exploited the ability of M. tuberculosis to induce host cell 138 death, which is linked to ESX-1-related secretion (5, 7) . To this aim, THP-1 human 139 macrophages were infected with the mycP1 and eccE1 mutants as well as with the WT strain 140 and the survival of macrophages was monitored at 72h post-infection. In the presence of WT 141 M. tuberculosis, the survival of macrophages significantly decreased compared to the 142 uninfected control. In contrast, when macrophages were infected with strains lacking either 143 eccE1 and/or mycP1, the macrophages survived to levels similar to the non-infected control. 144 Importantly, the complemented mutant restored the WT phenotype (Fig 1) . This result indicates 145 that M. tuberculosis needs both EccE1 and MycP1 for cytotoxicity and that the absence of either 146 of these ESX-1 components leads to complete attenuation of M. tuberculosis ex vivo. 147 To exclude an infection defect that could impact macrophage survival and to validate the 148 attenuated phenotype displayed in the absence of eccE1 and/or mycP1, we determined the levels 149 of intracellular bacteria at 4h post-infection by colony forming units (CFU) enumeration. The 150 bacterial burden was similar for the WT and the mutants, indicating that all strains were 151 phagocytosed with similar efficiency (S2 Fig) . These results demonstrated that M. tuberculosis 152 does not require EccE1 or MycP1 to infect macrophages, but it does need both components to 153 induce host cell death.
154
EccE1 and MycP1 are essential for ESX-1-protein-secretion 155 To determine if EccE1 and MycP1 are crucial to the function of the ESX-1 machinery, we 156 checked whether the deletion of eccE1 and/or mycP1 impacts ESX-protein secretion. To this EsxA and EsxB were not detected in culture filtrates of strains lacking eccE1 and/or mycP1 162 although both substrates were present in the cell lysates. Furthermore, secretion of EsxA and 163 EsxB was restored in the fully complemented strain DmycP1-eccE1/mycP1-eccE1 (Fig 2A) . 164 These data indicate that both EccE1 and MycP1 are required for secretion of the two main ESX-165 1 substrates. In contrast, EspB, another known ESX-1 substrate, was found in the cell lysates 166 and culture filtrates of the WT, mutant and complemented strains (Fig 2A) , suggesting that 167 secretion of EspB is independent of EccE1 or MycP1. Overall, we conclude that expression of 168 EsxA, EsxB and EspB is not affected by the absence of EccE1 or MycP1. However, both ESX-169 1 membrane proteins are essential for EsxA and EsxB secretion but dispensable for the release 170 of EspB into the culture filtrate. 171 To obtain deeper knowledge into the impact of EccE1 and MycP1 on M. tuberculosis secretion 172 and to identify potential EccE1-dependent substrates, the whole secretome of the mutants was 173 analyzed and compared to that of the WT strain (Table S5 ). Bacteria were grown in the same 174 conditions as previously described for immunoblotting and the secreted fraction analyzed by 175 mass spectrometry. We found that EsxA, EsxB, EspA and EspC were the only proteins 176 significantly reduced in the culture filtrates ( Fig 2B) . Moreover, in the WT strain, EsxA was in 177 the top ten most abundant proteins. On the other hand, the secretion of this protein greatly 178 decreased (Log2 ratio -5.1) when EccE1 and MycP1 were missing (Table S5 ). The same trend 179 was observed for EsxB, EspA and EspC whose secretion was also greatly decreased (Log2 ratio 180 [-7.8, -3.6] ) in the deletion mutants compared to the WT strain (Table S5 ). It was noteworthy 181 that the level of the other ESX-1-related proteins, including EspB, was not different in the 182 absence or presence of EccE1 and MycP1 ( Fig 2B) . Proteins using other secretion systems, such 183 as Ag85B, were secreted at similar levels in the WT and in the mutants ( Fig 2B) . Taken 184 together, the secretome analysis demonstrated that only secretion of EsxA, EsxB, EspA and 185 9 EspC is dependent on EccE1 and MycP1. This analysis also confirmed the previous results 186 obtained by immunoblotting.
187
EccE1, but not MycP1, impacts the stability of various ESX-1 membrane proteins 188 In order to evaluate whether the absence of EccE1 and MycP1 could affect the stability of other 189 ESX-1 membrane proteins, we analyzed the intracellular proteome of the mutants (DeccE1, 190 DmycP1, DmycP1-eccE1) and compared it to that of the WT strain (Table S6 ). As expected, 191 EccE1 and MycP1 were present in the WT and absent in the corresponding mutants. In addition, 192 the intracellular control proteins GroEL2 and RpoB were found at similar levels in all strains. 193 No significant differences were observed for EsxA, EsxB or EspB (Fig 3, S6 Table) , thus 194 corroborating the data obtained by immunoblot (Fig 2A) . However, in the absence of EccE1, 195 the levels of EccCa1, EccB1 and EccD1 were reduced (Figs 3A and 3C, S6 Table) . Interestingly, 196 the abundance of these membrane proteins did not change in the DmycP1 mutant compared to 197 the WT strain ( Fig 3B, S6 Table) . Considering the RNA-seq data, which showed no 198 deregulation of eccCa1, eccB1 and eccD1 transcription (S1 Table) , these data suggest that the 199 absence of EccE1, but not MycP1, impacted the stability of EccCa1, EccB1 and EccD1.
200
EccE1 is a membrane and cell wall-associated protein 201 Since antibodies against EccE1 of M. tuberculosis were not available, an HA tag was inserted 202 in the C-terminal part of EccE1 by genetic engineering, as recently applied to other ESX-1-203 related proteins with success (29). For this purpose, the double mutant DmycP1-eccE1 was 204 complemented with an integrative plasmid carrying mycP1 and eccE1-HA (DmycP1-205 eccE1/mycP1-eccE1HA). Both genes were present in single copy and expressed under the 206 control of the same promoter, PTR. To ensure that the tag did not interfere with the activity of 207 EccE1, the ability of the HA-tagged complemented mutant to induce cell lysis was tested. The 208 THP-1 ex vivo model of infection confirmed that the EccE1-HA expressing mutant was as 10 cytolytic as the WT strain, thereby implying the presence of a functional ESX-1 system and 210 so, a functional EccE1 protein ( Fig 4A) . 211 EccE1 is predicted to be a membrane protein in M. tuberculosis. Subcellular fractionation of 212 the mutant carrying eccE1-HA was therefore performed and the cytosolic, membrane, cell wall, 213 capsular and secreted fractions probed by immunoblotting using control proteins of known 214 subcellular location to validate the procedure. RpoB, an RNA polymerase subunit, was found 215 mainly in the cytosol and partly in the membrane. Rv3852, a membrane protein, was only 216 present in the membrane fraction as previously described (30). EsxB, a substrate of the ESX-1 217 system, was detected in the cytosol and to a lesser extent in the capsule although it was mainly 218 found in the culture filtrate. Finally, EccE1 was identified in the membrane and cell wall but 219 not in other compartments of M. tuberculosis ( Fig 4B) . EccE1 with mNeon, a 27 kDa monomeric fluorescent protein reported to be three to five times 226 brighter than GFP and export-competent (31-33). To generate the EccE1-mNeon expressing 227 strain, the same strategy used for generating the DmycP1-eccE1/mycP1-eccE1-HA was followed. 228 The complemented derivative (DmycP1-eccE1/mycP1-eccE1mNeon) has a single copy of mycP1 229 and eccE1-mNeon genes under the control of the PTR promoter, which provides expression of 230 EccE1-mNeon close to physiological levels. To check whether fusion to mNeon impacted 231 EccE1 function, the cytotoxic phenotype of the complemented mutant was analyzed using 232 THP-1 macrophages. The EccE1-mNeon expressing mutant induced cell death similarly to the 233 WT strain ( Fig 5B) , suggesting that this mutant can form a functional ESX-1 secretion system. 234 Since the WT copy of EccE1 is not present in the mutant and this protein is required for ESX- In the present study, we constructed and employed mutants and genetic tools to understand the 250 localization and functional role in M. tuberculosis of EccE1, an as yet unexplored ESX-1 251 membrane protein. We demonstrate that the absence of EccE1 does not impact antibiotic 252 susceptibility or bacterial growth in vitro ( Fig S1) whereas EccE1 is essential for macrophage 253 lysis, a function required for M. tuberculosis pathogenesis (Fig 1) . To the best of our 254 knowledge, this is the first time that disruption of the core component EccE1 in M. tuberculosis 255 has proved to lead to complete attenuation ex vivo. 256 Analysis of the ESX-1-secretome explains this phenotype as secretion of EsxA, EsxB, EspA 257 and EspC, which is essential to promote virulence (12, 13, 20) , was found to be strongly 258 dependent on EccE1 (Fig. 2) . Proteomic data showed no significant variations in the 259 intracellular levels of EsxA, EsxB, EspA and EspC when EccE1 and MycP1 were missing ( Fig   260 3), indicating that the reduced secretion of these ESX-1 substrates is due to disruption of the 261 secretion process and not to decreased protein production. The same phenotype was also 262 observed in the DmycP1 mutant, confirming that MycP1 is essential for EsxA/B secretion and 263 virulence in M. tuberculosis, as previously reported (21). However, secretion of EspB was not 264 affected by the absence of EccE1 and/or MycP1 suggesting that secretion of this protein is not 265 ESX-1 dependent ( Fig 2) and that another mechanism may be involved, as postulated earlier 266 for EspD (35) . In contrast with our findings, EspB secretion was previously reported to require The analysis of the intracellular proteome also revealed the impact of EccE1 on the stability of 279 ESX-1 membrane proteins and, therefore, formation of the ESX-1 membrane complex (Fig 3) . 280 It is plausible that in the absence of EccE1, the EccB1, EccCa1, EccD1 and EccCb1 proteins, 281 may not properly assemble or fold and hence become more vulnerable to degradation. In line 282 with these results, Bosserman and colleagues (37) recently demonstrated that the lack of 283 EccCb1 in M. marinum led to reduced levels of various ESX-1 membrane proteins including 284 EccE1. Together, these results support the hypothesis that loss of a single Ecc protein 285 destabilizes the ESX-1 complex. In contrast, the absence of MycP1 did not affect the 286 intracellular levels of the ESX-1 membrane proteins suggesting that the membrane complex is 287 probably formed in the protease-deficient mutant. Consistent with this, previous work on M. 288 marinum reported the formation of the ESX-1 core membrane complex in the absence of the 289 MycP1 mycosin (23), which is not itself an integral part of the ESX-1 apparatus but nonetheless 290 crucial for its integrity and function (23). 291 We confirmed that EccE1, with its two N-terminal transmembrane regions (38), is indeed a 292 membrane-anchored protein (Fig 4) with its hydrophilic C-terminal part predicted to be in the 293 periplasm. However, detection of the EccE1-mNeon protein in the cell wall fraction (Fig 4) as 294 well suggests that EccE1 also localizes there and thus behaves similarly to EccB1, another core 295 component of ESX-1 with two localizations. Indeed, EccB1, a periplasmic protein with a single 296 transmembrane region, was found in both the plasma membrane and cell wall fractions (39). 297 These observations are consistent with the structure of the ESX-5 membrane complex where 298 the soluble domain of EccE5 was predicted to be located in the periplasmic space (24). 299 Two previous studies demonstrated the presence of ESX-1 core components at a single cell 300 pole in M. marinum and M. smegmatis using immunofluorescence and microscopy analysis of 301 single cells overexpressing fluorescent fusion proteins (26, 27) . In this study, we localized 302 EccE1-mNeon at both poles of M. tuberculosis, using low level expression ( Fig 5A) , but only 303 when a functional ESX-1 apparatus was present. In its absence, the EccE1-mNeon signal was 304 diffuse and observed throughout the cell ( Fig 5) . These observations suggest that since EccE1 305 is localized at the poles in M. tuberculosis the ESX-1 apparatus may be there too. To test this, 306 the EccE1-mNeon protein constructed here may prove to be a useful tool for visualizing the 307 nanomachine in situ by correlative light-electron microscopy.
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MATERIAL AND METHODS
309
Bacterial culture conditions 310 M. tuberculosis was routinely grown in 7H9 broth (supplemented with 0.2% glycerol, 10% 311 ADC, 0.05% Tween-80) or on 7H10 agar (supplemented with 0.5% glycerol and 10% OADC). 312 Escherichia coli TOP10 or chemically-competent E. coli DH5a cells were used for cloning 313 and plasmid propagation and were grown on LB broth or agar.
314
Mutant construction 315 Deletion of the mycP1-eccE1 region was accomplished in the H37Rv strain by two-step 316 homologous recombination using the pJG1100-derived vector (40). Two fragments of ~900 bp 317 corresponding to the up-and downstream regions of mycP1-eccE1 were PCR-amplified and 318 inserted in pJG1110 vector. The first recombination event was selected on 7H10 plates with 319 hygromycin (50 µg/ml) and kanamycin (20µg/ml). Positive colonies identified by PCR were 320 grown in 7H9 medium with no antibiotics and subjected to a second selection on 7H10 plates 321 supplemented with 2.5% sucrose. The absence of mycP1-eccE1 in the resulting clones was 322 scored by PCR and further confirmed by Southern blotting.
323
DNA extraction and whole-genome sequencing 324 The M. tuberculosis DmycP1-eccE1 mutant was grown in 7H9 broth to OD600 0.8. Bacteria 325 were harvested by centrifugation and DNA was extracted using the QIAmp UCP pathogen 326 kit (Qiagen) as described previously (41). Ilumina libraries were prepared using the Kapa 327 Hyper prep kit as described (41) Complemented derivative constructions 334 The integrative pGA44 vector (43) was used to construct all complemented derivates. All 335 plasmids used in this study are listed in Table S3 . Briefly, the genes of interest were PCR 336 amplified from M. tuberculosis H37Rv genomic DNA (Table S4) Table S3 and Table S4 .
342
RNA-sequencing 343 M. tuberculosis strains were grown in 25 ml of Sauton's medium without detergent to OD600 ~ 344 0.5. Then, cultures were harvested by centrifugation and the resulting pellets resuspended in 345 1 mL TRIzol Reagent (ThermoFisher) and stored at -80°C until further processing. Bacteria 346 were disrupted by bead-beating and total RNA was isolated as previously described (44) In vitro growth curves 354 All strains were diluted to an initial OD600 of 0.05 in Middlebrook 7H9 medium, and the OD600 355 recorded at different time points over a period of 7 days. Data from three independent 356 experiments were used for growth representation.
357
Antibiotic susceptibility 358 The MIC values were determined by using the resazurin-based microdilution assay (REMA) 359 (28) as previously described (45) Mass spectrometry-based analysis 395 Proteins for secretion analysis (culture filtrates) were prepared as described above. To prepare 396 the cell lysate, the cell pellet was washed once with PBS, resuspended in 100mM Tris pH 8, 397 2% SDS buffer with Roche protease inhibitor cocktail tablets, disrupted by sonication for 15 398 min at 4°, clarified by centrifugation and heat-inactivated at 100°C for 1h. Total protein 399 18 concentration in all preparations was determined using the BCA assays. Mass spectrometry 400 analysis was performed as described previously (36). Significant hits were determined by a 401 volcano plot-based strategy, combining t test p-values with ratio information (46). Significance 402 curves in the volcano plot corresponding to a SO value of 0.5 and a permutation-based False 403 Discovery Rate (FDR) of 0.05 were determined by a permutation-based method. The FDR was 404 determined after 250 random permutations of the data allowing separation of biologically 405 significant hits from those randomly obtained (46, 47 The PRIDE database and related tools and resources in 2019: improving support for quantification 576 data. Nucleic Acids Res 47:D442-D450. 577 Table S4 . Oligonucleotides used in this study. 667   Table S5 . Secretome of the mutants compared to that of the WT strain. 668 Table S6 . Intracellular proteome of the mutants compared to that of the WT strain. Detection of Ag85B was used as a loading control in the CF and GroEL2 as a loading control in the CL. Secretion of EsxA and EsxB but not EspB is disrupted in the ΔeccE 1 , ΔmycP 1 -eccE 1 , and ΔmycP 1 mutants. B. Proteomic analysis of the secreted fraction comparing the ΔmycP 1 -eccE 1 mutant with the H37Rv WT strain. Each dot corresponds to an identified protein. Proteins are represented using a volcano plot-based strategy where t test p-values on the -log base 10 scale are combined with ratio information on the log base 2 scale. The blue dotted line represents the significant curve (SO value of 0.5) and it delineates the differentially quantified proteins. Three independent biological replicates per strain were analyzed and a t-test (significance level of 0.05) was used for statistical comparison. The abundance of EsxA, EsxB, EspA and EspC is highly affected in the double mutant ΔmycP 1 -eccE 1 compared to the WT strain. EsxA, EsxB, EspA and EspC are the only significantly reduced proteins. Proteins are represented using a volcano plot-based strategy where t test p-values on the -log base 10 scale are combined with ratio information on the log base 2 scale. The blue dotted line represents the significant curve (SO value of 0.5) and it delineates the differentially quantified proteins. Three independent biological replicates per strain were analyzed and a t-test (significance level of 0.05) was used for statistical comparison. In pink: ESX-1 membrane proteins. In blue: ESX-1 secreted proteins and intracellular protein controls. A. ΔmycP 1 -eccE 1 /mycP 1 versus WT. B. ΔmycP 1 -eccE 1 /eccE 1 versus WT. C. ΔmycP 1 -eccE 1 versus WT.
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